Medeze Group PCL (BKK:MEDEZE) Piotroski F-Score: N/A (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:MEDEZE Medeze Group PCL BKK:MEDEZE
19 GF Score
Price ฿6.20
! 5 Warning Signs
View Full Analysis

What is Medeze Group PCL Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medeze Group PCL has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Medeze Group PCL's Piotroski F-Score or its related term are showing as below:

During the past 3 years, the highest Piotroski F-Score of Medeze Group PCL was 4. The lowest was 4. And the median was 4.

Medeze Group PCL  (BKK:MEDEZE) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medeze Group PCL Piotroski F-Score Related Terms


Medeze Group PCL Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Medeze Group PCL's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeze Group PCL Piotroski F-Score Chart

Medeze Group PCL Annual Data
Trend Dec23 Dec24 Dec25
Piotroski F-Score
8.00 5.00 5.00

Medeze Group PCL Quarterly Data
Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 5.00 5.00 6.00

BKK:MEDEZE vs HCA, THC, EHC: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Medeze Group PCL's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeze Group PCL Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medeze Group PCL's Piotroski F-Score falls into.


BKK:MEDEZE
19GF Score
Medeze Group PCL BKK:MEDEZE
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 30.536 + 36.431736 + 34.364 + 40.182 = ฿141.5 Mil.
Cash Flow from Operations was 74.755 + 2.606728 + 84.367 + 36.599 = ฿198.3 Mil.
Revenue was 170.253 + 174.89306 + 163.309 + 159.329 = ฿667.8 Mil.
Gross Profit was 120.373 + 122.279286 + 123.04 + 116.714 = ฿482.4 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(3506.341 + 3507.603 + 3478.123794 + 3538.947 + 3488.895) / 5 = ฿3503.9819588 Mil.
Total Assets at the begining of this year (Jun25) was ฿3,506.3 Mil.
Long-Term Debt & Capital Lease Obligation was ฿0.0 Mil.
Total Current Assets was ฿1,694.1 Mil.
Total Current Liabilities was ฿100.4 Mil.
Net Income was 94.685 + 98.267952 + 74.628 + 54.785 = ฿322.4 Mil.

Revenue was 226.678 + 198.92328 + 205.077 + 193.425 = ฿824.1 Mil.
Gross Profit was 178.69 + 152.750894 + 159.642 + 145.029 = ฿636.1 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(1198.797 + 1047.253 + 3429.038729 + 3537.761 + 3506.341) / 5 = ฿2543.8381458 Mil.
Total Assets at the begining of last year (Jun24) was ฿1,198.8 Mil.
Long-Term Debt & Capital Lease Obligation was ฿0.0 Mil.
Total Current Assets was ฿2,002.7 Mil.
Total Current Liabilities was ฿132.4 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medeze Group PCL's current Net Income (TTM) was 141.5. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medeze Group PCL's current Cash Flow from Operations (TTM) was 198.3. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=141.513736/3506.341
=0.04035938

ROA (Last Year)=Net Income/Total Assets (Jun24)
=322.365952/1198.797
=0.26890787

Medeze Group PCL's return on assets of this year was 0.04035938. Medeze Group PCL's return on assets of last year was 0.26890787. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medeze Group PCL's current Net Income (TTM) was 141.5. Medeze Group PCL's current Cash Flow from Operations (TTM) was 198.3. ==> 198.3 > 141.5 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=0/3503.9819588
=0

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=0/2543.8381458
=0

Medeze Group PCL's gearing of this year was 0. Medeze Group PCL's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=1694.074/100.355
=16.88081311

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=2002.684/132.424
=15.12327071

Medeze Group PCL's current ratio of this year was 16.88081311. Medeze Group PCL's current ratio of last year was 15.12327071. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medeze Group PCL's number of shares in issue this year was 1068. Medeze Group PCL's number of shares in issue last year was 1068. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=482.406286/667.78406
=0.72239862

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=636.111894/824.10328
=0.77188371

Medeze Group PCL's gross margin of this year was 0.72239862. Medeze Group PCL's gross margin of last year was 0.77188371. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=667.78406/3506.341
=0.1904504

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=824.10328/1198.797
=0.68744189

Medeze Group PCL's asset turnover of this year was 0.1904504. Medeze Group PCL's asset turnover of last year was 0.68744189. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medeze Group PCL has an F-score of 6 indicating the company's financial situation is typical for a stable company.


Medeze Group PCL Business Description

Address Phuttha Monthon Sai 4 Road, 28/9 Moo 8, Krathum Lom, Sam Phran, Nakhon Pathom, THA, 73220
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score

Get the complete analysis for BKK:MEDEZE

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿6.20
Price